Akebia tries for FDA approval of anemia drug after mixed data

Retrieved on: 2021-03-30 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Akebia tries for FDA approval of anemia drug after mixed data. View article details on hiswai:

Excerpt

The FDA now has 60 days to determine whether Akebia's application is complete and ready for an official review. Recommended Reading: BioPharma ...

Article found on: www.biopharmadive.com